Intrinsiqq
Bio-UV Group SAS logo

Bio-UV Group SAS Quality Score

ALTUV.XPAR

⊜ Compare
Quality39

Weak across most dimensions. This doesn't mean avoid, but the burden of proof is on the bull case.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
90/100
12.9x

Under 20x, reasonable relative to earnings

Cash Flow Multiple
100/100
3.5x

Under 20x cash flow, well covered

Revenue Growth
0/100
-11.2%

Below 2%, essentially flat

Cash Flow Growth
100/100
84.5%

Above 10% CAGR, strong compounder

Business Quality & Capital Allocation

Share Dilution
0/100
33.6%

Heavy dilution above 5%

Margin Trend
0/100
-3.8pp

Contracted >2pp, margin pressure

Capital Structure
0/100
€10M

Net debt/FCF of 3.4x, high leverage

2022
€2.00M
€34.0M
2023
€3.00M
€39.0M
2024
€4.00M
€30.0M
2025
€10.0M
€20.0M
CashDebt
Return on Capital
0/100
2.3%

Below 8%, may not cover cost of capital

Customize WeightsPremiumUpgrade

Bio-UV Group SAS (ALTUV.XPAR) quality: score, margins and returns

Bio-UV Group SAS (ALTUV.XPAR) scores 39/100 on Intrinsiqq's quality score (a lower-quality business), a weighted blend of 8 metrics each scored 0 to 100, on 4.3% operating margins and 2.3% ROIC. Every metric is computed from company filings; this is analysis, not investment advice.

Frequently asked

Is Bio-UV Group SAS (ALTUV.XPAR) a high-quality business?+

Bio-UV Group SAS scores 39 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which rates it a lower-quality business on these measures. Recent figures include a 4.3% operating margin and a 2.3% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Bio-UV Group SAS's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from ALTUV.XPAR's company filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Bio-UV Group SAS scores well and where it falls behind.

What is Bio-UV Group SAS's return on invested capital (ROIC)?+

Bio-UV Group SAS earns about 2.3% on its invested capital, which is weak. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to ALTUV.XPAR's margins and growth on this scorecard to judge durability.

How profitable is Bio-UV Group SAS?+

Bio-UV Group SAS runs an operating margin of about 4.3% and a net margin of about 2.3%. Revenue has grown at roughly 1.8% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from company filings, not investment advice.

More on ALTUV.XPAR: Overview · DCF valuation · Dividend safety · Financials
How the market compares: US profitability statistics

Peers

Pollution & Treatment Controls · Pick stocks to compare with ALTUV.XPAR

CompareIntrinsic value
ALORA.XPARAltheora S.A.
€0.32+3.23%33
ALTPC.XPARMarseille Tunnel Prado-Carénage S.A.
€21.20+0.47%63
GEA.XPARGEA Group Aktiengesellschaft
€69.50+0.72%68
ALAQU.XPARAquila S.A.
€3.80+11.11%34
ALMCE.XPARMon Courtier Energie Groupe
€5.50+1.85%55
ALMGI.XPARMg International Inc.
€2.24-2.61%39
ALTRI.XPARTrilogiq S.A.
€4.82-0.41%67
ALODY.XPAROdyssee Technologies Inc.
€15.22+7.03%52

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ALTUV.XPAR

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.